Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Digoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Breast Neoplasms 4 Neoplasms 3 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Healthy Participants 2 Advanced Solid Tumor 2 cMET-dysregulated Advanced Solid Tumors 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Solid Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Liver Cirrhosis 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Head and Neck Neoplasms 1 Drug-drug Interaction,SHR3680 1 Colorectal Neoplasms 1 Advanced Solid Malignancies 1 Advanced Pancreatic Cancer 1

Interventions

Iodine-131 19 lenvatinib 15 Sorafenib 11 trametinib 10 Thyrotropin Alfa 10 Magnetic Resonance Spectroscopy 10 pembrolizumab 9 Thyroidectomy 9 Surgical Procedures, Operative 9 vandetanib 8 dabrafenib 8 Thyroxine 8 Paclitaxel 8 selpercatinib 7 anlotinib 6 Sunitinib 6 Everolimus 6 pazopanib 5 cabozantinib 5 Vemurafenib 5 Triiodothyronine 5 Saline Solution 5 Nivolumab 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 Biopsy, Fine-Needle 5 Radiofrequency Ablation 4 Iodine-124 4 Docetaxel 4 Dexmedetomidine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05507775 2024-04-11

DIGUP-TC

Radboud University Medical Center

Phase NA Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡